Morning Scientific Session

This session will showcase the latest advances in experimental platforms that reduce reliance on animal testing while improving human relevance. Speakers will highlight innovative organoid models, microphysiological systems (MPS), and in chemico approaches that offer mechanistic insight and translational value in human disease research.

Dr. Ellen Shrock, University of Washington
Antibody Immunodominance is Germline-Encoded

Dr. Weida Tong, NCTR/FDA
From Animals to Algorithms: AI in DILI Risk Evaluation

Dr. Shehzad Z. Sheikh, University of North Carolina at Chapel Hill